Abstract
Chronic kidney disease (CKD) and hypertension can cause, and are known for their associations with one another. The rising affliction with diabetes and hypertension has led to the increasing prevalence of CKD and end-stage kidney disease (ESKD). The burden of hypertension depends on many factors. Asia houses a variety of ethnic groups which plays a role in variability of socioeconomic status, dietary patterns, lifestyle habits, and attitudes to healthcare. All of which contribute to the heterogeneous prevalence of hypertension and CKD within the region, or even country, thereby emphasizing the importance of identifying gaps in healthcare and implementing crucial national strategies to control hypertension and curb CKD progression.
For this chapter, focusing on countries in Asia, we review the following: (1) epidemiology of hypertension and CKD; (2) relationship of hypertension and CKD with clinical outcomes; (3) genetics associated with hypertension and CKD; (4) impact of sodium and dietary patterns; and (5) antihypertensives prescription patterns.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kidney Disease: Improving Global Outcomes Blood Pressure Work G. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3S):S1–S87. https://doi.org/10.1016/j.kint.2020.11.003.
Teo BW, Chan GC, Leo CCH, Tay JC, Chia YC, Siddique S, et al. Hypertension and chronic kidney disease in Asian populations. J Clin Hypertens (Greenwich). 2021;23(3):475–80. https://doi.org/10.1111/jch.14188.
Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–22. https://doi.org/10.1016/S0140-6736(12)60033-6.
Zheng Y, Tang L, Zhang W, Zhao D, Zhang D, Zhang L, et al. Applying the new intensive blood pressure categories to a nondialysis chronic kidney disease population: the Prevalence, Awareness and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China survey. Nephrol Dial Transplant. 2020;35(1):155–61. https://doi.org/10.1093/ndt/gfy301.
Surveilance and Epidemiology Branch CfHP, Department of Health, Hong Kong Special Administrative Region Government. Report of population survey 2014/2015. 2017.
Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170–7. https://doi.org/10.1097/HJH.0000000000000146.
Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, et al. Epidemiology and risk factors of chronic kidney disease in India—results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol. 2013;14:114. https://doi.org/10.1186/1471-2369-14-114.
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235–481. https://doi.org/10.1038/s41440-019-0284-9.
Chia YC, Kario K, Turana Y, Nailes J, Tay JC, Siddique S, et al. Target blood pressure and control status in Asia. J Clin Hypertens (Greenwich). 2020;22(3):344–50. https://doi.org/10.1111/jch.13714.
Hooi LS, Ong LM, Ahmad G, Bavanandan S, Ahmad NA, Naidu BM, et al. A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia. Kidney Int. 2013;84(5):1034–40. https://doi.org/10.1038/ki.2013.220.
Subramanian S, Teo BW, Toh QC, Koh YY, Li J, Sethi S, et al. Spot urine tests in predicting 24-hour urine sodium excretion in Asian patients. J Ren Nutr. 2013;23(6):450–5. https://doi.org/10.1053/j.jrn.2012.12.004.
Korean Society H, Hypertension Epidemiology Research Working G, Kim HC, Cho MC. Korea hypertension fact sheet 2018. Clin Hypertens. 2018;24:13. https://doi.org/10.1186/s40885-018-0098-0.
Park JI, Baek H, Jung HH. Prevalence of chronic kidney disease in Korea: the Korean National Health and Nutritional Examination Survey 2011-2013. J Korean Med Sci. 2016;31(6):915–23. https://doi.org/10.3346/jkms.2016.31.6.915.
Health Promotion Administration, Ministry of Health and Welfare, Taiwan. Nutrition and Health Survey in Taiwan (NAHSIT) Report 2013–2016.
Cai G. Etiology, comorbidity and factors associated with renal function decline in Chinese chronic kidney disease patients. J Am Soc Nephrol. 2011;22:183A–4A.
Ho YW, Chau K, Choy BY, et al. Hong Kong renal registry report 2010. Hong Kong J Nephrol. 2010;12(2):81–98.
Jha V. Current status of end-stage renal disease care in India and Pakistan. Kidney Int Suppl. 2013;3(2):157–60.
Masakane I, Taniguchi M, Nakai S, et al. Annual dialysis data report 2016, JSDT renal data registry. Ren Replace Ther. 2018;4:45.
Registry SR. First report of the Singapore renal registry 1997. 1998.
Kim YS, Jin DC. Global dialysis perspective: Korea. Kidney360. 2020;1:52–7.
Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton). 2010;15(Suppl 2):3–9. https://doi.org/10.1111/j.1440-1797.2010.01304.x.
Alencar de Pinho N, Levin A, Fukagawa M, Hoy WE, Pecoits-Filho R, Reichel H, et al. Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease. Kidney Int. 2019;96(4):983–94. https://doi.org/10.1016/j.kint.2019.04.032.
Sabanayagam C, Lim SC, Wong TY, Lee J, Shankar A, Tai ES. Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol Dial Transplant. 2010;25(8):2564–70. https://doi.org/10.1093/ndt/gfq084.
Sabanayagam C, Teo BW, Tai ES, Jafar TH, Wong TY. Ethnic differences in the association between blood pressure components and chronic kidney disease in middle aged and older Asian adults. BMC Nephrol. 2013;14:86. https://doi.org/10.1186/1471-2369-14-86.
Lew QLJ, Allen JC, Nguyen F, Tan NC, Jafar TH. Factors associated with chronic kidney disease and their clinical utility in primary care clinics in a multi-ethnic Southeast Asian population. Nephron. 2018;138(3):202–13. https://doi.org/10.1159/000485110.
Sabanayagam C, Shankar A, Lim SC, Tai ES, Wong TY. Hypertension, hypertension control, and chronic kidney disease in a Malay population in Singapore. Asia Pac J Public Health. 2011;23(6):936–45. https://doi.org/10.1177/1010539510361637.
Wan EYF, Yu EYT, Chin WY, Fong DYT, Choi EPH, Lam CLK. Association of blood pressure and risk of cardiovascular and chronic kidney disease in Hong Kong hypertensive patients. Hypertension. 2019;74(2):331–40. https://doi.org/10.1161/HYPERTENSIONAHA.119.13123.
Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P, et al. Risk factors for development of decreased kidney function in a Southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005;16(3):791–9. https://doi.org/10.1681/ASN.2004030208.
Jiang C, Wang B, Li Y, Xie L, Zhang X, Wang J, et al. U-shaped association between serum albumin and development of chronic kidney disease in general hypertensive patients. Clin Nutr. 2020;39(1):258–64. https://doi.org/10.1016/j.clnu.2019.02.002.
Yano Y, Fujimoto S, Sato Y, Konta T, Iseki K, Iseki C, et al. New-onset hypertension and risk for chronic kidney disease in the Japanese general population. J Hypertens. 2014;32(12):2371–7.; ; discussion 7. https://doi.org/10.1097/HJH.0000000000000344.
Kang YU, Bae EH, Ma SK, Kim SW. Determinants and burden of chronic kidney disease in a high-risk population in Korea: results from a cross-sectional study. Korean J Intern Med. 2016;31(5):920–9. https://doi.org/10.3904/kjim.2014.243.
Chang TI, Lim H, Park CH, Rhee CM, Moradi H, Kalantar-Zadeh K, et al. Associations of systolic blood pressure with incident CKD G3-G5: a cohort study of South Korean adults. Am J Kidney Dis. 2020;76(2):224–32. https://doi.org/10.1053/j.ajkd.2020.01.013.
Saminathan TA, Hooi LS, Mohd Yusoff MF, Ong LM, Bavanandan S, Rodzlan Hasani WS, et al. Prevalence of chronic kidney disease and its associated factors in Malaysia; findings from a nationwide population-based cross-sectional study. BMC Nephrol. 2020;21(1):344. https://doi.org/10.1186/s12882-020-01966-8.
Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010;25(5):1567–75. https://doi.org/10.1093/ndt/gfp669.
Yan Z, Wang Y, Li S, Wang J, Zhang L, Tan H, et al. Hypertension control in adults with CKD in China: baseline results from the Chinese cohort study of chronic kidney disease (C-STRIDE). Am J Hypertens. 2018;31(4):486–94. https://doi.org/10.1093/ajh/hpx222.
Yuan J, Zou XR, Han SP, Cheng H, Wang L, Wang JW, et al. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol. 2017;18(1):23. https://doi.org/10.1186/s12882-017-0441-9.
Anupama YJ, Hegde SN, Uma G, Patil M. Hypertension is an important risk determinant for chronic kidney disease: results from a cross-sectional, observational study from a rural population in South India. J Hum Hypertens. 2017;31(5):327–32. https://doi.org/10.1038/jhh.2016.81.
Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, Nitta K, et al. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study. Clin Exp Nephrol. 2017;21(3):446–56. https://doi.org/10.1007/s10157-016-1309-1.
Li Y, Li D, Song Y, Gao L, Fan F, Wang B, et al. Visit-to-visit variability in blood pressure and the development of chronic kidney disease in treated general hypertensive patients. Nephrol Dial Transplant. 2020;35(10):1739–46. https://doi.org/10.1093/ndt/gfz093.
Li Y, Zhou H, Liu M, Liang M, Wang G, Wang B, et al. Association of visit-to-visit variability in blood pressure and first stroke risk in hypertensive patients with chronic kidney disease. J Hypertens. 2020;38(4):610–7. https://doi.org/10.1097/HJH.0000000000002306.
Hirayama A, Konta T, Kamei K, Suzuki K, Ichikawa K, Fujimoto S, et al. Blood pressure, proteinuria, and renal function decline: associations in a large community-based population. Am J Hypertens. 2015;28(9):1150–6. https://doi.org/10.1093/ajh/hpv003.
Chia YC, Lim HM, Ching SM. Long-term visit-to-visit blood pressure variability and renal function decline in patients with hypertension over 15 years. J Am Heart Assoc. 2016;5(11):e003825. https://doi.org/10.1161/JAHA.116.003825.
Cha RH, Kim S, Ae Yoon S, Ryu DR, Eun OJ, Han SY, et al. Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: results of the APrODiTe study. Hypertens Res. 2014;37(2):172–8. https://doi.org/10.1038/hr.2013.127.
Azushima K, Wakui H, Uneda K, Haku S, Kobayashi R, Ohki K, et al. Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease. Clin Exp Hypertens. 2017;39(7):665–71. https://doi.org/10.1080/10641963.2017.1313850.
Wain LV, Vaez A, Jansen R, Joehanes R, van der Most PJ, Erzurumluoglu AM, et al. Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney. Hypertension. 2017. https://doi.org/10.1161/HYPERTENSIONAHA.117.09438.
Wuttke M, Li Y, Li M, Sieber KB, Feitosa MF, Gorski M, et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet. 2019;51(6):957–72. https://doi.org/10.1038/s41588-019-0407-x.
Liu L, Wang C, Mi Y, Liu D, Li L, Fan J, et al. Association of MYH9 polymorphisms with hypertension in patients with chronic kidney disease in China. Kidney Blood Press Res. 2016;41(6):956–65. https://doi.org/10.1159/000452597.
Redon J, Chaves FJ, Liao Y, Pascual JM, Rovira E, Armengod ME, et al. Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension. Hypertension. 2000;35(1 Pt 2):490–5. https://doi.org/10.1161/01.hyp.35.1.490.
Tripathi G, Dharmani P, Khan F, Sharma RK, Pandirikkal V, Agrawal S. High prevalence of ACE DD genotype among north Indian end stage renal disease patients. BMC Nephrol. 2006;7:15. https://doi.org/10.1186/1471-2369-7-15.
Su SL, Lu KC, Lin YF, Hsu YJ, Lee PY, Yang HY, et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensin II type 1 receptor among chronic kidney disease patients in a Chinese population. J Renin-Angiotensin-Aldosterone Syst. 2012;13(1):148–54. https://doi.org/10.1177/1470320311430989.
Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res. 2003;26(7):521–5. https://doi.org/10.1291/hypres.26.521.
Lin DS, Wang TD, Buranakitjaroen P, Chen CH, Cheng HM, Chia YC, et al. Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: evidence from Asia and around the globe. J Clin Hypertens (Greenwich). 2021;23(3):556–67. https://doi.org/10.1111/jch.14120.
Liu Y, Shi M, Dolan J, He J. Sodium sensitivity of blood pressure in Chinese populations. J Hum Hypertens. 2020;34(2):94–107. https://doi.org/10.1038/s41371-018-0152-0.
Liu Z, Qi H, Liu B, Liu K, Wu J, Cao H, et al. Genetic susceptibility to salt-sensitive hypertension in a Han Chinese population: a validation study of candidate genes. Hypertens Res. 2017;40(10):876–84. https://doi.org/10.1038/hr.2017.57.
Nierenberg JL, Li C, He J, Gu D, Chen J, Lu X, et al. Blood pressure genetic risk score predicts blood pressure responses to dietary sodium and potassium: The GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity). Hypertension. 2017;70(6):1106–12. https://doi.org/10.1161/HYPERTENSIONAHA.117.10108.
Qi H, Liu B, Guo C, Liu Z, Cao H, Liu K, et al. Effects of environmental and genetic risk factors for salt sensitivity on blood pressure in northern China: the systemic epidemiology of salt sensitivity (EpiSS) cohort study. BMJ Open. 2018;8(12):e023042. https://doi.org/10.1136/bmjopen-2018-023042.
Rhee MY, Yang SJ, Oh SW, Park Y, Kim CI, Park HK, et al. Novel genetic variations associated with salt sensitivity in the Korean population. Hypertens Res. 2011;34(5):606–11. https://doi.org/10.1038/hr.2010.278.
Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. 2020;76(3 Suppl 1):S1–S107. https://doi.org/10.1053/j.ajkd.2020.05.006.
Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al. Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3):559–69. https://doi.org/10.1016/j.kint.2020.10.026.
Schweda F. Salt feedback on the renin-angiotensin-aldosterone system. Pflugers Arch. 2015;467(3):565–76. https://doi.org/10.1007/s00424-014-1668-y.
Kotchen TA, Cowley AW Jr, Frohlich ED. Salt in health and disease—a delicate balance. N Engl J Med. 2013;368(26):2531–2. https://doi.org/10.1056/NEJMc1305326.
Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:406960. https://doi.org/10.1155/2014/406960.
Sanghavi S, Vassalotti JA. Dietary sodium: a therapeutic target in the treatment of hypertension and CKD. J Ren Nutr. 2013;23(3):223–7. https://doi.org/10.1053/j.jrn.2013.01.027.
Zhao L, Stamler J, Yan LL, Zhou B, Wu Y, Liu K, et al. Blood pressure differences between northern and southern Chinese: role of dietary factors: the International Study on Macronutrients and Blood Pressure. Hypertension. 2004;43(6):1332–7. https://doi.org/10.1161/01.HYP.0000128243.06502.bc.
Ma G. The salt consumption of resident in China. Chinese J Prev Control Chronic Dis. 2008;16(4):214–7.
Shao S, Hua Y, Yang Y, Liu X, Fan J, Zhang A, et al. Salt reduction in China: a state-of-the-art review. Risk Manag Healthc Policy. 2017;10:17–28. https://doi.org/10.2147/RMHP.S75918.
Zhai FY, Du SF, Wang ZH, Zhang JG, Du WW, Popkin BM. Dynamics of the Chinese diet and the role of urbanicity, 1991-2011. Obes Rev. 2014;15(Suppl 1):16–26. https://doi.org/10.1111/obr.12124.
Health Promotion Board GoS. National Nutrition Survey 2010. 2010.
Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3(12):e003733. https://doi.org/10.1136/bmjopen-2013-003733.
Chan GC, Teo BW, Tay JC, Chen CH, Cheng HM, Wang TD, et al. Hypertension in a multi-ethnic Asian population of Singapore. J Clin Hypertens (Greenwich). 2021;23(3):522–8. https://doi.org/10.1111/jch.14140.
He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013;(4):CD004937. https://doi.org/10.1002/14651858.CD004937.pub2.
de Brito-Ashurst I, Perry L, Sanders TA, Thomas JE, Dobbie H, Varagunam M, et al. The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial. Heart. 2013;99(17):1256–60. https://doi.org/10.1136/heartjnl-2013-303688.
Konishi Y, Okada N, Okamura M, Morikawa T, Okumura M, Yoshioka K, et al. Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin a nephropathy. Hypertension. 2001;38(1):81–5. https://doi.org/10.1161/01.hyp.38.1.81.
McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, et al. A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol. 2013;24(12):2096–103. https://doi.org/10.1681/ASN.2013030285.
Meuleman Y, Hoekstra T, Dekker FW, Navis G, Vogt L, van der Boog PJM, et al. Sodium restriction in patients with CKD: a randomized controlled trial of self-management support. Am J Kidney Dis. 2017;69(5):576–86. https://doi.org/10.1053/j.ajkd.2016.08.042.
Saran R, Padilla RL, Gillespie BW, Heung M, Hummel SL, Derebail VK, et al. A randomized crossover trial of dietary sodium restriction in stage 3-4 CKD. Clin J Am Soc Nephrol. 2017;12(3):399–407. https://doi.org/10.2215/CJN.01120216.
Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ. 2011;343:d4366. https://doi.org/10.1136/bmj.d4366.
Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol. 2008;19(5):999–1007. https://doi.org/10.1681/ASN.2007060693.
Xu J, Wang M, Chen Y, Zhen B, Li J, Luan W, et al. Estimation of salt intake by 24-hour urinary sodium excretion: a cross-sectional study in Yantai, China. BMC Public Health. 2014;14:136. https://doi.org/10.1186/1471-2458-14-136.
Jardine MJ, Li N, Ninomiya T, Feng X, Zhang J, Shi J, et al. Dietary sodium reduction reduces albuminuria: a cluster randomized trial. J Ren Nutr. 2019;29(4):276–84. https://doi.org/10.1053/j.jrn.2018.10.009.
Evans RG, Subasinghe AK, Busingye D, Srikanth VK, Kartik K, Kalyanram K, et al. Renal and dietary factors associated with hypertension in a setting of disadvantage in rural India. J Hum Hypertens. 2021. https://doi.org/10.1038/s41371-020-00473-5.
Koh KH, Wei-Soon LH, Jun L, Lui-Sian LN, Hui-Hong CT. Study of low salt diet in hypertensive patients with chronic kidney disease. Med J Malaysia. 2018;73(6):376–81.
Wakasugi M, James Kazama J, Narita I. Associations between the intake of miso soup and Japanese pickles and the estimated 24-hour urinary sodium excretion: a population-based cross-sectional study. Intern Med. 2015;54(8):903–10. https://doi.org/10.2169/internalmedicine.54.4336.
Health Research and Development Agency MoHRoI. Basic Health Research Report. 2018.
Teo BW, Bagchi S, Xu H, Toh QC, Li J, Lee EJ. Dietary sodium intake in a multiethnic Asian population of healthy participants and chronic kidney disease patients. Singap Med J. 2014;55(12):652–5. https://doi.org/10.11622/smedj.2014180.
Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16(2):97–103. https://doi.org/10.1038/sj.jhh.1001307.
Amano H, Kobayashi S, Terawaki H, Ogura M, Kawaguchi Y, Yokoo T. Measurement of daily sodium excretion in patients with chronic kidney disease; special reference to the difference between the amount measured from 24 h collected urine sample and the estimated amount from a spot urine. Ren Fail. 2018;40(1):238–42. https://doi.org/10.1080/0886022X.2018.1456452.
Mun KH, Yu GI, Choi BY, Kim MK, Shin MH, Shin DH. Association of dietary potassium intake with the development of chronic kidney disease and renal function in patients with mildly decreased kidney function: the Korean Multi-Rural Communities Cohort Study. Med Sci Monit. 2019;25:1061–70. https://doi.org/10.12659/MSM.913504.
Kim J, Lee J, Kim KN, Oh KH, Ahn C, Lee J, et al. Association between dietary mineral intake and chronic kidney disease: the Health Examinees (HEXA) Study. Int J Environ Res Public Health. 2018;15(6):1070. https://doi.org/10.3390/ijerph15061070.
Sacks FM, Obarzanek E, Windhauser MM, Svetkey LP, Vollmer WM, McCullough M, et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol. 1995;5(2):108–18. https://doi.org/10.1016/1047-2797(94)00055-x.
Svetkey LP, Sacks FM, Obarzanek E, Vollmer WM, Appel LJ, Lin PH, et al. The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc. 1999;99(8 Suppl):S96–104. https://doi.org/10.1016/s0002-8223(99)00423-x.
Lee HS, Lee KB, Hyun YY, Chang Y, Ryu S, Choi Y. DASH dietary pattern and chronic kidney disease in elderly Korean adults. Eur J Clin Nutr. 2017;71(6):755–61. https://doi.org/10.1038/ejcn.2016.240.
Jhee JH, Kee YK, Park JT, Chang TI, Kang EW, Yoo TH, et al. A diet rich in vegetables and fruit and incident CKD: a community-based prospective cohort study. Am J Kidney Dis. 2019;74(4):491–500. https://doi.org/10.1053/j.ajkd.2019.02.023.
Lew QJ, Jafar TH, Koh HW, Jin A, Chow KY, Yuan JM, et al. Red meat intake and risk of ESRD. J Am Soc Nephrol. 2017;28(1):304–12. https://doi.org/10.1681/ASN.2016030248.
Song Y, Lobene AJ, Wang Y, Hill Gallant KM. The DASH diet and cardiometabolic health and chronic kidney disease: a narrative review of the evidence in East Asian countries. Nutrients. 2021;13(3):984. https://doi.org/10.3390/nu13030984.
Zhang W, Shi W, Liu Z, Gu Y, Chen Q, Yuan W, et al. A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease. Sci Rep. 2016;6:38768. https://doi.org/10.1038/srep38768.
Teo BW, Chua HR, Wong WK, Haroon S, Subramanian S, Loh PT, et al. Blood pressure and antihypertensive medication profile in a multiethnic Asian population of stable chronic kidney disease patients. Singap Med J. 2016;57(5):267–73. https://doi.org/10.11622/smedj.2016089.
Jessani S, Bux R, Jafar TH. Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan—a community based cross-sectional study. BMC Nephrol. 2014;15:90. https://doi.org/10.1186/1471-2369-15-90.
Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, et al. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol. 2010;14(6):558–70. https://doi.org/10.1007/s10157-010-0328-6.
Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, et al. Kidney health for everyone everywhere-from prevention to detection and equitable access to care. Kidney Int. 2020;97(2):226–32. https://doi.org/10.1016/j.kint.2019.12.002.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chan, G.C., Li, P.KT. (2022). Hypertension and Chronic Kidney Disease in Asians. In: Ram, C.V.S., Teo, B.W.J., Wander, G.S. (eds) Hypertension and Cardiovascular Disease in Asia. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-030-95734-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-95734-6_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-95733-9
Online ISBN: 978-3-030-95734-6
eBook Packages: MedicineMedicine (R0)